^
Association details:
Biomarker:CHRNA6 overexpression
Cancer:Lung Cancer
Drug Class:Immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

Involvement of CHRNA6 in the Immune Response in Lung Squamous Cell Carcinoma and its Potential as a Drug Target for the Disease

Published date:
09/08/2023
Excerpt:
In addition, LUSC patients with higher CHRNA6 expression levels had better immunotherapy responses.
DOI:
10.2174/1381612829666230901143203